Skip to main content
. 2013 Oct 8;472(4):1232–1239. doi: 10.1007/s11999-013-3316-9

Table 2.

Costs associated with obesity (estimates derived from multivariate linear regression models)

Analytical sample Cost per five-unit increase in BMI greater than 30 kg/m2
Hospitalization costs (USD) 95% CI Total 90-day costs (USD) 95% CI
All patients undergoing primary and revision THA
Adjusted for age, sex, surgery type, surgical indication $744 $499–$989 $1183 $851–$1516
Adjusted for age, sex, surgery type, surgical indication, comorbidities $600 $360–$841 $1019 $692–$1347
Excluding patients with significant comorbidities* and adjusted for age, sex, surgery type, surgical indication $657 $381–$932 $1053 $747–$1359
Excluding patients with complications, adjusted for age, sex, surgery type, surgical indication, comorbidities $606 $404–$807 $953 $682–$1224
Patients undergoing primary THA
Adjusted for age, sex $620 $439–$801 $906 $628–$1184
Adjusted for age, sex, comorbidities $495 $319–$670 $845 $575–$1115
Excluding patients with significant comorbidities# and adjusted for age, sex $550 $353–$746 $954 $622–$1285
Patients undergoing revision THA
Adjusted for age, sex, surgical indication $895 $290–$1499 $1547 $744–$2350
Adjusted for age, sex, surgical indication, comorbidities $609 $19–$1199 $1170 $383–$1957
Excluding patients with significant comorbidities* and adjusted for age, sex, surgical indication $892 $421–$1362 $1367 $639–$1294

* Patients with selected comorbidities that are significantly associated with costs are excluded; patients older than 25 years undergoing primary THA with degenerative arthritis and no recorded malignancies or metastases; patients older than 25 years undergoing revision THA and no recorded malignancies or metastases.